BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/14/2025 10:33:53 AM | Browse: 134 | Download: 790
 |
Received |
|
2024-10-04 07:12 |
|
Peer-Review Started |
|
2024-10-04 07:12 |
|
First Decision by Editorial Office Director |
|
2024-11-09 19:21 |
|
Return for Revision |
|
2024-11-10 08:16 |
|
Revised |
|
2024-11-21 07:44 |
|
Publication Fee Transferred |
|
2024-12-16 03:49 |
|
Second Decision by Editor |
|
2025-01-08 02:37 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-01-08 07:55 |
|
Articles in Press |
|
2025-01-08 07:55 |
|
Edit the Manuscript by Language Editor |
|
2025-01-14 02:29 |
|
Typeset the Manuscript |
|
2025-01-21 02:45 |
|
Publish the Manuscript Online |
|
2025-02-14 10:33 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Immunology |
| Manuscript Type |
Basic Study |
| Article Title |
Irreversible electroporation combined with anti-programmed cell death protein 1 therapy promotes tumor antigen-specific CD8+ T cells response
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yang-Yang Ma, Xiao-Hua Wang, Jian-Ying Zeng, Ji-Bing Chen and Li-Zhi Niu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Science and Technology Program of Guangzhou |
202102010077 |
| International Science Foundation of Guangzhou Fuda Cancer Hospital |
Y2020-ZD-03 |
|
| Corresponding Author |
Li-Zhi Niu, Chief Physician, MD, PhD, Department of Oncology, Guangzhou Fuda Cancer Hospital, No. 2 Tangde West Road, Tianhe District, Guangzhou 510665, Guangdong Province, China. niuboshi@fudahospital.com |
| Key Words |
Irreversible electroporation; Pancreatic cancer; Programmed cell death protein 1 blockade; CD8+ T cell; Anticancer immunity |
| Core Tip |
This study highlights the synergistic effect of combining irreversible electroporation with anti-programmed cell death protein 1 therapy in the treatment of subcutaneous pancreatic cancer. The combination significantly enhances T lymphocyte infiltration, elevates key cytokine levels, and promotes CD8+ T cell-mediated immune responses, resulting in a marked reduction in tumor volume. These findings suggest a promising avenue for improving immunotherapy strategies in pancreatic cancer through enhanced local tumor ablation methods. |
| Publish Date |
2025-02-14 10:33 |
| Citation |
Ma YY, Wang XH, Zeng JY, Chen JB, Niu LZ. Irreversible electroporation combined with anti-programmed cell death protein 1 therapy promotes tumor antigen-specific CD8+ T cells response. World J Gastrointest Oncol 2025; 17(3): 101991 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i3/101991.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i3.101991 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
